Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Usefulness of Gadovist-enhanced FLAIR Imaging in Differentiation Between a Glioblastoma and Solitary Brain Metastasis: Single Center Prospective Study

NCT05293990 is registered in ClinicalTrials.gov with Ryoo, In Seon as lead sponsor.

NCT NCT05293990
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05293990 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Usefulness of Gadovist-enhanced FLAIR Imaging in Differentiation Between a Glioblastoma and Solitary Brain Metastasis: Single Center Prospective Study
Lead sponsor
Ryoo, In Seon
Phase
Not applicable
Overall status
Completed
Start date
February 2, 2017
Completion date
January 25, 2021
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain lymphoma, cns lymphoma, malignant tumors